CHMP medtog i sine overvejelser, at der findes kliniske alternativer, dvs. seksvalente vacciner eller tilsvarende kombinationsvacciner, som indeholder de samme komponenter som Hexavac.
The CHMP considered that clinical alternatives exist, i. e. hexavalent vaccines or equivalent combinations of vaccines containing the same components as Hexavac.